• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Cutaneous Connection: Episode 32-Understanding Type 2 Inflammation

Podcast

In this episode, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and more!

In this episode of The Cutaneous Connection, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and why physicians should educate their patients about this type of inflammation.

Related Videos
Related Content
Atopic Dermatitis Identified as Possible Risk Factor for Headache Disorders, Migraine

Atopic Dermatitis Identified as Possible Risk Factor for Headache Disorders, Migraine

Article
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Podcast
New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates

New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates

Article
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath

The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath

Podcast
Probiotics Cannot Replace Standard of Care Atopic Dermatitis Therapies, Research Letter Argues

Probiotics Cannot Replace Standard of Care Atopic Dermatitis Therapies, Research Letter Argues

Article
Countdown to RAVE!

Countdown to RAVE!

Article
© 2024 MJH Life Sciences

All rights reserved.